ESC 365 - Which antithrombotic therapy after transcatheter aortic valve procedure (TAVI)?

ESC Premium Access

Which antithrombotic therapy after transcatheter aortic valve procedure (TAVI)?

Session: Current controversies in antithrombotic therapy

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor S. Windecker (Bern, CH)

Event: ESC Asia with APSC & AFC 2021

Presentation

About the speaker

Professor Stephan Windecker

Bern University Hospital, Inselspital, Bern (Switzerland)

29 presentations

4 followers

3 more presentations in this session

Aspirin in primary prevention: is it still valid?

Speaker: Professor J. Armitage (Oxford, GB)

Which antithrombotic therapy after percutaneous coronary intervention (PCI)?

Speaker: Professor K. Park (Seoul, KR)

Current controversies in antithrombotic therapy - panel discussion.

Access the full session

Current controversies in antithrombotic therapy

Speakers: Professor S. Windecker, Professor J. Armitage, Professor K. Park

About the event

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Congress

This platform is supported by